Market Size in 2021 | Market Forecast in 2028 | Growth Rate (in %) | Base Year |
---|---|---|---|
USD 570.1 million | USD 818.2 million | CAGR at 4.8% | 2021 |
The global microcrystalline cellulose market is likely to grow from $570.1 million in 2021 to $818.2 million by the end of 2028. It is likely to exhibit exponential growth with a healthy CAGR of 4.8% during the forecast period. The report offers in-depth analyses of the growth factors, opportunities, and challenges in the market during the forecast period.
Microcrystalline cellulose is refined wood pulp adopted as a bulking agent, extender, texturizer, fat substitute, emulsifier, anticaking agent, and others. It is largely used as a supplement in the form of a tablet. It is extracted with the help of a controlled hydrolysis process. Purified alpha-cellulose extracted from natural wood cellulose with mineral acid is hydrolyzed to produce microcrystalline cellulose. It is a partial deep polymerized cellulose in pure form. There are many ways to synthesize microcrystalline cellulose like enzyme-mediated synthesis, steam explosion acid hydrolysis, and reactive exclusion. Microcrystalline cellulose is used in a number of applications in the personal care, food, pharmaceutical, and cosmetic sector. It is also found in ice cream, whipped cream, and frozen yogurts. Most of the low-fat dairy products contain microcrystalline cellulose.
The outbreak of the Covid-19 pandemic has significantly impacted the growth trajectory of the global microcrystalline cellulose market, as many end-user sectors were badly affected by the pandemic landscape. The worldwide lockdowns imposed bans on travel, sales, and purchases along with retail business closures. Sectors like cosmetics were severely affected. However, pharmaceuticals, a major end-user of microcrystalline cellulose, experienced a spike in demand during the Covid-19 pandemic due to the growing cases of hospitalization, which in turn has strongly fueled the growth of the global market.
High demand from the pharmaceutical sector will fuel the growth of the global market.
Microcrystalline cellulose is massively used as an excipient in the pharmaceutical sector owing to its superior compressibility properties. It is majorly utilized in the form of solid-like tablets. It functions as direct compression excipients which work like anti-adherent, filler, absorbent, tablet disintegrant, and dry binder. It is utilized in both direct compression and wet granulation processes for capsule and oral tablet formulations. Its properties like disintegrant and lubricant make it ideal for direct tableting. The pharmaceutical segment is growing exponentially in several regions all across the globe, which in turn is also likely to spike the demand for microcrystalline cellulose in the market. The constantly growing production of pharmaceutical products, particularly in emerging countries like India, China, and Brazil, is likely to drive the growth of the global microcrystalline cellulose market in the forthcoming years.
Availability of substitutes will hamper the growth of the global market.
Microcrystalline cellulose has majorly no available substitutes, but there are few products that are better than microcrystalline cellulose and can be highly used in special applications. A few of such products include carboxymethyl cellulose (CMC), croscarmellose sodium, kappa-carrageenan, and others. These products are widely being used in the food and beverage sector to stabilize baking products and ice creams.
Growing inclination towards non-wood-based microcrystalline cellulose is likely to create new growth opportunities in the global market.
Microcrystalline cellulose is currently manufactured with the help of wood pulp. However, production is quite expensive for manufacturers. Therefore, manufacturers are finding non-wood sources better than wood pulp. Non-wood sources include agricultural waste and have no environmental impact. Such new techniques are still in process. But such technology is likely to pose a huge growth opportunity in the global market in the forthcoming years.
Production of glucose microcrystalline cellulose is a huge challenge in the global market.
Manufacturing microcrystalline cellulose requires several steps like drying, bleaching, washing, and acid hydrolysis before the production of the end product. Therefore, it raises the cost of the production of microcrystalline cellulose. Manufacturers are striving hard to lower the overall production of non-wood-based microcrystalline cellulose, and therefore, it has emerged as a huge challenge in the global market.
Report Attributes | Report Details |
---|---|
Report Name | Microcrystalline Cellulose Market Research Report |
Market Size in 2021 | USD 570.1 million |
Market Forecast in 2028 | USD 818.2 million |
Growth Rate | CAGR of 4.8% |
Number of Pages | 177 |
Key Companies Covered | MingTai Chemical Co. Ltd, Sigachi Industries Pvt. Ltd, JRS PHARMA GmbH & Co. KG, Accent Microcell Pvt. Ltd, DFE Pharma GmbH & Co.KG, Roquette, Asahi Kasei Chemicals Corporation, FMC Corporation, Rayonier Advanced Material, and DowDuPont. |
Segments Covered | By application, By source type, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2021 |
Historical Year | 2018 to 2021 |
Forecast Year | 2022 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The global microcrystalline cellulose market can be segmented into source type, application, and region.
By source type, the market can be segmented into non-wood and wood-based sources.
By application, the market can be segmented into cosmetics & personal care, food & beverage, pharmaceuticals, and others.
Recent Developments
Asia Pacific accounts for the largest share in the global microcrystalline cellulose market due to the fast proliferating end-user sector in the region. Furthermore, the constantly growing disposable income of the people in the region will further complement the growth of the market. There is high demand for low-fat dairy products in the region, which is likely to accentuate the growth of the regional market.
Some of the significant players in the global microcrystalline cellulose market include:
By application
By source type
By Region
FrequentlyAsked Questions
Microcrystalline cellulose is massively used as an excipient in the pharmaceutical sector owing to its superior compressibility properties. It is majorly utilized in the form of solid-like tablets. It functions as direct compression excipients which work like anti-adherent, filler, absorbent, tablet disintegrant, and dry binder.
The global microcrystalline cellulose market is likely to grow from $570.1 million in 2021 to $818.2 million by the end of 2028. It is likely to exhibit exponential growth with a healthy CAGR of 4.8% during the forecast period.
Some of the significant players in the global microcrystalline cellulose market include MingTai Chemical Co. Ltd, Sigachi Industries Pvt. Ltd, JRS PHARMA GmbH & Co. KG, Accent Microcell Pvt. Ltd, DFE Pharma GmbH & Co.KG, Roquette, Asahi Kasei Chemicals Corporation, FMC Corporation, Rayonier Advanced Material, and DowDuPont.
Asia Pacific accounts for the largest share in the global microcrystalline cellulose market due to the fast proliferating end-user sector in the region. Furthermore, the constantly growing disposable income of the people in the region will further complement the growth of the market.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed